On spatial discretisation in the calculus of subcutaneous insulin absorption profiles

International Mediterranean Modelling Multiconference, I3M

Volumn , Issue , 2006, Pages 379-384

  Tarn, Cristina ^a   Bondia, Sauer Jorge ^a   Veh́, Edgar Teufel Josep ^a  

^a UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

Diabetes Care; Discretisation; Infusion Process; Insulin Analogues; Pharmacokinetic Modelling

Indexed keywords

DEVELOPED MODEL; DIABETES CARE; DISCRETISATION; HOMOGENEOUS SHELLS; INFUSION PROCESS; INSULIN ANALOGUES; SPHERICAL VOLUME;

CALCULATIONS;

INSULIN;

EID: 84870170172     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (9)

1. [Gessler, 2000] Gessler, R. (2000). Ein portables System zur subkutanen Messung und Regelung der Glukose bei Diabetes mellitus Typ-I. PhD thesis, Abteilung Allgemeine Elektrotechnik und Mikroelektronik an der Universität Ulm.
2. [Höfig, 1996] Höfig, B. (1996). Physiologische Modellierung des menschlichen Glukose-Metabolismus für die simulationsgestützte Therapie des insulinabh ängigen Diabetes mellitus. PhD thesis, Universität Stuttgart, Institut A für Mechanik.
3. [Lepore et al., 2000] Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P., and Bolli, G. (2000). Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, nph insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes, 49:2142-8.
4. [Luzio et al., 2003] Luzio, S. D., Beck, P., and Owens, D. R. (2003). Comparison of the Subcutaneous Absorption of Insulin Glargine (Lantus) and NPH Insulin in Patients with Type 2 Diabetes. Horm Metab Res, 35:434-438.
5. [Mosekilde et al., 1989] Mosekilde, E., Jensen, K., Binder, C., Pramming, S., and Thorsteinsson, B. (1989). Modelling absorption kinetics of subcutaneous injected soluble insulin. J. Pharmakokinet. Biopharm., 17:67-87.
6. [Nucci and Cobelli, 2000] Nucci, G. and Cobelli, C. (2000). Models of subcutaneous insulin kinetics. A critical review. Computer Methods and Programs in Biomedicine, 62:249-57.
7. [Owens et al., 2000] Owens, D., Coates, P., Luzio, S., Tinbergen, J., and Kurzhals, R. (2000). Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care, 23:813-9.
8. [Tar'in et al., 2005] Tar'in, C., Teufel, E., Pic'o, J., Bondia, J., and Pfleiderer, H.-J. (2005). Comprehensive pharmacokinetic model of insulin glargine and other insulin formulations. IEEE Transactions on Biomedical Engineering, 52(12):1994-2005.
9. [Trajanoski et al., 1993] Trajanoski, Z., Wach, P., Kotanko, P., Ott, A., and Skraba, F. (1993). Pharmacokinetic model for the absorption of subcutaneously injected soluble insulin and monomeric insulin analogues. Biomedizinische Technik, 38(9):224-31.